About
Technology
Issues
FAQ
Links
Official Page
A phase 2 study of BGJ398 in patients (pts) with advanced or metastatic FGFR-altered cholangiocarcinoma (CCA) who failed or are intolerant to platinum-based chemotherapy.
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.